Smaller Doses Of 2-Dose Mpox Vaccine Produce Detectable Immune Responses In Patients With And Without HIV Infection Regardless Of Vaccination Route, Study Finds

January 08, 2024

Infectious Disease Advisor (1/5, Nye) reported, “Smaller doses of the 2-dose mpox vaccine produce detectable immune responses in patients with and without HIV infection regardless of vaccination route.” The findings were published in The New England Journal of Medicine.